Pharmaceutical - Victoza, Asia-Pacific

Filter

Current filters:

VictozaAsia-Pacific

Popular Filters

South Korea's type 2 diabetes drug market to grow to over $550 million in 2016

23-10-2012

The type 2 diabetes therapeutic market in South Korea will grow 11% annually from $330 million in 2011…

AmylinAsia-PacificBydureonDiabetesJanumetJanuviaMarkets & MarketingMerck & CoNovo NordiskPharmaceuticalVictoza

AstraZeneca to investment $200 million in Chinese manufacturing plant; Novo Nordisk debuts Victoza

10-10-2011

Anglo-Swedish drug major AstraZeneca ILSE: AZN) said this morning that it is investing $200 million in…

Asia-PacificAstraZenecaDiabetesFinancialMarkets & MarketingNovo NordiskPharmaceuticalRegulationVictoza

Company Spotlight

ImmunoGen

ImmunoGen

Back to top